Glycine and neuroprotective effect of hypothermia in hypoxic-ischemic brain damage

NeuroReport

Volumn 13, Issue 16, 2002, Pages 1995-2000

  Kvrivishvili, Giuli ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b INSTITUTE OF PHYSICS   (Georgia)

Author keywords

Glutamate; Glycine; Hypothermia; Hypoxia ischemia; Neuroprotection; Neurotoxicity

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; 7 CHLOROKYNURENIC ACID; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTOXIN;

BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TEMPERATURE; DRUG ACTIVITY; HUMAN; HYPOTHERMIA; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; GLUTAMIC ACID; GLYCINE; HUMANS; HYPOTHERMIA; HYPOXIA-ISCHEMIA, BRAIN;

EID: 0037113344     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200211150-00001     Document Type: Review

References (129)

1. Ginsberg MD, Sternau LL, Globus MY et al. Cerebrovasc Brain Metab Rev 4, 189-225 (1992).
2. Thoresen M, Bagenholm R, Loberg EM et al. Arch Dis Childh 74, F3-F9 (1996).
3. Illievich UM, Zornow MH, Choi KT and Scheller MS. Anesthesiology 80, 177-186 (1994).
4. Busto R, Dietrich WD, Globus MY-T et al. J Cerebr Blood Flow Metab 7, 729-738 (1987).
5. Sano T, Drummond JC, Patel PH et al. Anesthesiology 76, 221-228 (1992).
6. Busto R, Globus MY-T, Dietrich D et al. Stroke 20, 904-910 (1989).
7. Michenfelder JD and Theye RA. Anesthesiology 9, 1107-1112 (1968).
8. Rothman SM. Science 220, 536-537 (1983).
9. Rothman SM. J Neurosci 4, 1884-1891 (1984).
10. Rothman SM and Olney JW. Ann Neurol 19, 105-111 (1986).
11. Simon RP, Swan JH, Griffiths T and Meldrum BS. Science 22, 850-852 (1984).
12. Baker AJ, Zornow MH, Scheller MS et al. J Neurochem 57, 1370-1379 (1991).
13. Cassady CJ, Phillis JW, O'Regan MH. Brain Res 901, 30-37 (2001).
14. Globus MY-T, Ginsberg MD, Dietrich WD et al. Neurosci Lett 80, 251-256 (1987).
15. Globus MY-T, Busto R, Dietrich WD et al. J Neurochem 51, 1455-1464 (1988).
16. Globus MY-T, Busto R, Dietrich WD et al. Neurosci Lett 91, 36-40 (1988).
17. Nakashima K and Todd MM. Stroke 27, 913-918 (1996).
18. Tang XC, Rao MR, Hu G and Wang H. Acta Pharmacol Sin 21, 819-823 (2000).
19. Barks JDE and Silverstein FS. 1992. Brain Pathol 2, 235-243 (1992).
20. Hagberg H, Andine P and Lehmann A. Excitatory amino acids and hypoxic-ischemic damage in the immature brain. In: Schurr A and Rigor BM, eds. Cerebral Ischemia and Resusitation. Boca Raton, FL: CRC Press; 1990, pp. 165-177.
21. Ikonomidou C, Price MT, Mosinger JL et al. J Neurosci 9, 1693-1700 (1989).
22. Johnston MV. Clin Invest Med 16, 122-132 (1993).
23. Johnston MV and Silverstein FS. Perinatal anoxia. In: Coyle JT, ed. Animal Models of Dementia. New York: Alan R. Liss; 1987, pp. 223-251.
24. Volpe JJ. Ment Retard Dev Disabil Res Rev 7, 56-64 (2001).
25. Hagberg H, Andersson P, Kjellmer I et al. Neurosci Lett 78, 311-317 (1987).
26. Andine P, Sandberg M, Bagenholm R et al. Dev Brain Res 64, 115-120 (1991).
27. Thoresen M, Satas S, Puka-Sunvall M et al. Neuroreport 8, 3359-3362 (1997).
28. Benveniste H, Jorgensen M, Sandberg M et al. J Cerebr Blood Flow Metab 9, 629-639 (1989).
29. Choi DW, Koh J-Y and Peters S. J Neurosci 8, 185-196 (1988).
30. Ikonomidou C and Turski L. Crit Rev Neurobiol 10, 239-63 (1996).
31. Jabaudon D, Scanziani M, Gahwiler BH, Gerber U. Proc Natl Acad Sci USA 97, 5610-5615 (2000).
32. Johansen FF, Jorgensen MB and Diemer NH. Brain Res 377, 344-347 (1986).
33. Onodera H, Sato G and Kogure K. Neurosci Lett 68, 169-174 (1986).
34. Wieloch T, Lindvall O, Blomqvist P and Gage FH. Neurol Res 7, 24-26 (1985).
35. Buchan A and Pulsinelli WA. J Neurosci 10, 311-316 (1990).
36. Corbett D, Nurse S and Colbourne F. Stroke 28, 2238-2242 (1997).
37. Minamisawa H, Nordstrom C-H, Smith M-L, Siesjo BK. J Cerebr Blood Flow Metab 10, 365-374 (1990).
38. Welsh FA, Sims RE and Harris VA. J Cerebr Blood Flow Metab 10, 557-563 (1990).
39. Bona E, Hagberg H, Loberg EM et al. Pediatr Res 43, 738-745 (1998).
40. Fukuda H, Tomimatsu T, Watanabe N et al. Brain Res 910, 187-191 (2001).
41. Haaland K, Loberg EM, Steen PA and Thoresen M. Pediatr Res 41, 505-512 (1997).
42. Sirimanne ES, Blumberg RM, Bossano D et al. Pediatr Res 39, 591-597 (1996).
43. Thoresen M, Penrice J, Lorek A et al. Pediatr Res 37, 667-670 (1995).
44. Towfighy J, Housman C, Heitjan DF et al. Acta Neuropathol (Berl) 87, 598-604 (1994).
45. Williams GD, Dardzinski BJ, Buckalew AR and Smith MB. Pediatr Res 42, 700-708 (1997).
46. Scremin A, Scremin OU and Brechner T. Stroke 11, 548-552 (1980).
47. Young RSK, Olenginski TP, Yagel SK and Towfighy J. Stroke 14, 929-934 (1983).
48. Ooboshi H, Ibayashi S, Takano K et al. Brain Res 884, 23-30 (2000)
49. Baker AJ, Zornow MH, Grafe MR et al. Stroke 22, 666-673 (1991).
50. Lo EH, Steinberg GK, Panahian N et al. Neurol Res 15, 281-287 (1993).
51. Matsumoto M, Scheller MS, Zornow MH and Strnat MA. Stroke 24, 1228-1234 (1993).
52. Mitani A and Kataoka K. Neuroscience 42, 661-670 (1991).
53. Patel PM, Drummond JC, Cole DJ and Yaksh TL. Brain Res 650, 205-211 (1994).
54. Yamamoto H, Mitani A, Cui Y et al. Neuroscience 91, 501-509 (1999).
55. Nakashima K and Todd MM. Anesthesiology 85, 161-168 (1996).
56. Choi DW. Stroke, Suppl 21, III20-III23 (1990).
57. Erecinska M and Silver IA. Prog Neurobiol 35, 245-296 (1990).
58. Choi DW. The excitotoxic concept. In: Welch KMA, Reis DJ, Calpan LR, Siesjo BK and Weir B, eds. Primer on Cerebrovascular Diseases. New York: Academic Press; 1997, pp. 187-190.
59. Olney JW. Neurotoxicity of excitatory amino acids. In: McGeer EG, Olney JW and McGeer PL, eds. Kainic Acid as a Tool in Neurobiology. New York: Raven; 1978, pp. 95-171.
60. Benveniste H, Drejer J, Schousboe A and Diemer NH. J Neurochem 43, 1369-1374 (1984).
61. Hagberg H, Lehmann A, Sandberg M et al. J Cerebr Blood Flow Metab 5, 413-419 (1985).
62. Choi DW and Rothman SM. Annu Rev Neurosci 13, 171-182 (1990).
63. MacDermott AB, Mayer ML, Westbrook GL et al. Nature 321, 519-522 (1986).
64. Baker CJ, Fiore AJ, Frazzini VI et al. Neurosurgery 36, 994-1001 (1995).
65. Boris-Möller F and Wieloch T. Exp Brain Res 121, 277-284 (1998).
66. Globus MY-T, Busto R, Martinez E et al. Stroke, Suppl 21, III43-III46 (1990).
67. Uckele JE, McDonald JW, Johnston MV and Silverstein FS. Neurosci Lett 107, 279-283 (1989).
68. Johnson JW and Ascher P. Nature 325, 529-531 (1987).
69. Kleckner N and Dingledine R. Science 241, 835-837 (1988).
70. McNamara D and Dingledine R. J Neurosci 10, 3970-3976 (1990).
71. Oliver MW, Kessler M, Larson J et al. Synapse 5, 265-270 (1990).
72. Parsons CG, Danysz W, Hesselink M et al. Amino Acids 14, 207-216 (1998).
73. Patel J, Zinkand WC, Thompson C et al. J Neurochem 54, 849-854 (1990).
74. Thomson AM. Prog Neurobiol 35, 53-74 (1990).
75. Yoneda Y, Ogita K and Suzuki T. J Neurochem 55, 237-244 (1990).
76. Wallis RA, Panizzon KL and Nolan JP. Brain Res 664, 115-125 (1994).
77. Globus MY, Busto R, Martinez E et al. J Neurochem 57, 470-478 (1991).
78. Graham SH, Shiraishi K, Panter SS et al. Neurosci Lett 110, 124-130 (1990).
79. Newell DW, Barth A, Riccardi TN and Malouf A. Exp Neurol 145, 235-244 (1997).
80. Danysz W, Wroblewski JT, Brooker G and Costa E. Brain Res 479, 270-276 (1989).
81. Salt TE. Brain Res 481, 403-406 (1989).
82. Singh L, Oles RJ and Tricklebank MD. Br J Pharmacol 99, 285-288 (1990).
83. Wood PL, Emmett MR, Rao TS et al. J Neurochem 53, 979-981 (1989).
84. Wood ER, Bussey TJ and Phillips AG. Neurosci Lett 145, 10-14 (1992).
85. Pace JR, Martin BM, Paul SM and Rogawaski MA. Neurosci Lett 141, 97-100 (1992).
86. Shahi K and Baudry M. Brain Res 627, 261-266 (1993).
87. Shahi K, Marvizon J-C and Baudry M. Neurosci Lett 149, 185-188 (1993).
88. Newell DW, Barth A and Malouf AT. Brain Res 675, 38-44 (1995).
89. Warner DS, Martin H, Ludwig P et al. J Cerebr Blood Flow Metab 15, 188-196 (1995).
90. Wood ER, Bussey TJ and Phillips AG. Neuroreport 4, 151-154 (1993).
91. Zafra F, Aragon C, Olivares L et al. J Neurosci 15, 3952-3969 (1995).
92. Globus MY-T, Ginsberg MD and Busto R. Neurosci Lett 127, 39-42 (1991).
93. Kim HK, Zornow MH, Snart MA and Maze M. J Neurosurg Aesthesiol 8, 230-236 (1996).
94. Araki T, Kato H, Fujiwara T et al. Eur J Pharmacol 278, 91-96 (1995).
95. Hawkinson JE, Huber KR, Sahota PS et al. Brain Res 744, 227-234 (1997).
96. Pellegrini-Giampietro DE, Cozzi A and Moroni F. Neuroscience 63, 701-709 (1994).
97. Chen J, Graham S, Moroni F and Simon R. J Pharmacol Exp Ther 267, 937-941 (1993).
98. Bordi F, Pietra C, Ziviani L and Reggiani A. Exp Neurol 145, 425-433 (1997).
99. Di Fabio R, Conti N, De Magistris E et al. J Med Chem 42, 3486-3493 (1999).
100. Reggiani A, Pietra C, Arban R et al. Eur J Pharmacol 419, 147-153 (2001).
101. Tatlisumak T, Takano K, Meiler MR and Fisher M. Stroke 29, 190-195 (1998).
102. Ohtani K, Tanaka H, Yasuda H et al. Brain Res 871, 311-318 (2000).
103. Hicks CA, Ward MA, Ragumoorthy N et al. Brain Res 819, 65-74 (1999).
104. Albers GW, Clark WM, Atkinson RP et al. Stroke 30, 508-513 (1999).
105. Clark GD and Rothman SM. Neuroscience 21, 665-671 (1987).
106. Gill R, Foster AC and Woodruff GN. J Neurosci 7, 3343-3349 (1987).
107. Gill R, Hargreaves RJ and Kemp JA. J Cerebr Blood Flow Metab 15, 197-204 (1995).
108. Kaas IS, Chambers G and Cottrell JE. Exp Neurol 103, 116-122 (1989).
109. Qiu H, Hedlund LW, Gewalt SL et al. J Magn Resort Imaging 7, 739-744 (1997).
110. Takano K, Tatlisumak T, Formato JE et al. Stroke 28, 1255-1262 (1997).
111. Choi DW. Neurosci Lett 58, 293-297 (1985).
112. Choi DW. J Neurosci 7, 369-379 (1987).
113. Marcoux FW, Probert AW Jr, Goodrich JE and Dominick MA. In: Cavaleiro EA, Lehmann J and Turski L (eds). Frontiers in Excitatory Amino Acid Research. New York: Alan R. Liss; 1988, pp. 683-686.
114. Rothman SM, Thurston JH and Hauhart RE. Neuroscience 22, 471-480 (1987).
115. Siesjo BK. Ann NY Acad Sci 522, 638-661 (1988).
116. Kloog Y, Lamdani-ltkin H and Sokolovsky M. J Neurochem 54, 1576-1583 (1990).
117. Fadda E, Danysz JT, Wroblewski JT and Costa E. Neuropharmacology 27, 1183-1185 (1988).
118. Bristow DR, Bowery NG and Woodruff GN. Eur J Pharmacol 126, 303-307 (1986).
119. Wroblewski JT, Fadda E, Mazzetta J et al. Neuropharmacology 28, 447-452 (1989).
120. Monaghan DT, Olverman HJ, Nguyen L et al. Proc Natl Acad Sci USA 85, 9836-9840 (1988).
121. Bertolino M, Vicini S, Mazzetta J and Costa E. Neurosci Lett 84, 331-355 (1988).
122. Huang FP, Zhou LF and Yang GY. Neurochem Res 23, 991-996 (1998).
123. McDonald JW, Uckele J, Silverstein FS and Johnston MV. Neurosci Lett 104, 167-170 (1989).
124. Lehmann A and Jacobson I. Eur J Neurosci 2, 620-628 (1990).
125. Wang GJ, Labruyere J, Price MT and Olney JW. Soc Neurosci Abstr 16, 198 (1990).
126. Simpson RE, Walter GA and Phillis JW. Neurosci Lett 124, 83-86 (1991).
127. Foster AC and Kemp JA. Nature 338, 377-378 (1989).
128. Dyker AG and Lees KR. Stroke 30, 986-992 (1999).
129. The North American Glycine Antagonist in Neuroprotection (GAIN) Investigators. Stroke 31, 358-365 (2000).